[Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)]

MeSH terms

• Antibodies, Monoclonal / administration & dosage
• Antibodies, Monoclonal / therapeutic use*
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / therapeutic use*
• Female
• Humans
• Injections, Intralesional
• Injections, Intravenous
• Lymphoma, B-Cell / drug therapy*
• Lymphoma, B-Cell / pathology
• Middle Aged
• Remission Induction
• Rituximab
• Skin / pathology
• Skin Neoplasms / drug therapy*
• Skin Neoplasms / pathology
• Time Factors